Likewise, angiogenesis-related IL-8 levels [145, 146] often elevated in tumor samples of patients with NSCLC [147] can be regulated by miR-200 which also targets growth regulated alpha protein (CXCL1) secreted by the tumor endothelial and cancer cells. The gene discussed is CXCL8; the disease is neoplasm.